Oriola as an investment
Oriola's share is listed on Nasdaq Helsinki with trading code ORIOLA. In 2024, Oriola's net sales were EUR 1.7 billion and we employ around 900 professionals in Finland and Sweden.
A leading wholesaler of pharmaceuticals and health products in Finland and Sweden
Oriola is a health and wellbeing company and part of the critical infrastructure in Finland and Sweden. As a leading wholesaler, we ensure the safe, reliable and efficient distribution of pharmaceuticals and health products to pharmacies, hospitals, veterinarians, medical clinics, retailers, e-commerce and other healthcare providers.
Stable market with solid market growth drivers
Oriola operates in a stable market, supported by solid growth drivers such as ageing population, demand for wellbeing and healthcare, and expansion of online pharmaceuticals and speciality products. Additionally, the deregulation of the Finnish pharmaceutical retail market may positively impact our operations.
Efficient and high-volume distribution of pharmaceuticals
Our distribution business provides logistics and dose dispensing services of pharmaceuticals and related products. We serve as the link between pharmaceutical companies and pharmacies, hospitals, veterinarians and other healthcare providers. Our strategic focus is on enhancing customer value by building strong partnerships and improving commercial focus and excellence.
Growing wholesale offering and entering new customer segments
In our wholesale business we offer a broad selection of traded goods and over-the-counter (OTC) products to a diverse customer base, including pharmacies, veterinarians and various retailers, both online and physical stores. Our strategic focus is to further expand our offering to efficiently meet market and consumer needs, and to ensure that our products are widely accessible across various sales channels in Finland and Sweden.
Expanding into new markets and leveraging commercial data solutions
Our advisory business provides expert services to pharmaceutical companies and pharmacies. We help our customers to navigate the complex pharmaceutical market and meet regulatory requirements in the Nordics. Our strategic focus is to build on strong customer relationships and to expand and grow the business through commercialising data and technology.
Positive impact on society and people’s lives
We believe that a sustainable future starts with health. Through our role as a wholesaler of pharmaceuticals and health products, we positively impact society and people’s lives. Our sustainable people journey guides our work in leadership, employee engagement, attracting new employees, as well as safety and wellbeing at work. We continuously work to minimise the environmental footprint of our business and are committed to setting science-based emission reduction targets.
Efficiency to drive profitability and cash generation
Large and stable volumes, combined with enhanced warehouse efficiency, support profitability improvement and stable cash generation. Oriola is investing in its infrastructure and technology by renewing and unifying its separate ERP and warehouse management systems in Sweden and Finland into one common system by 2027.